"Наша миссия: создавать будущее, в котором нет места болезням сердца. Более 30 лет центр успешно объединяет в себе кардиологическую клинику, исследовательский институт и образовательное учреждение. Такое сочетание обеспечивает уровень высоких международных стандартов в диагностике и лечении сердечно-сосудистых заболеваний. Сегодня нам доверяют свое здоровье тысячи пациентов из разных регионов России."

During the past decade, Tyumen Cardiology Center, conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tyumen Cardiology Center," #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Medtronic Bakken Research Center" with 2 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Anthera Pharmaceuticals" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tyumen Cardiology Center," #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "KCRI" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tyumen Cardiology Center," are "Cardiovascular Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Angina" (1 trials), "Angina Pectoris" (1 trials) and "Arrhythmia" (1 trials). Many other conditions were trialed in "Tyumen Cardiology Center," in a lesser frequency.

Most popular intervention types in "Tyumen Cardiology Center," are "Drug" (6 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Bioresorbable vascular scaffold (BVS) implantation" (1 trials), "CRT-P Implant" (1 trials) and "CRT-P OFF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tyumen Cardiology Center," are 11 trials for "All" genders.

Currently, there are NaN active trials in "Tyumen Cardiology Center,". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Tyumen Cardiology Center,, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tyumen Cardiology Center,, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".